Literature DB >> 9155584

Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils.

P Gionchetti1, M Vecchi, F Rizzello, M Ferretti, C Calabresi, A Venturi, M B Bianchi, C Brignola, R A Sinico, R De Franchis, M Miglioli, M Campieri.   

Abstract

BACKGROUND: Antineutrophil cytoplasmic antibodies (ANCAs) from patients with vasculitidis can induce neutrophils to release oxygen radicals in vitro. ANCAs with a perinuclear pattern of immunofluorescence are found in most patients with ulcerative colitis, but several findings are against ANCAs having a pathogenetic role in this disease. AIMS: To evaluate the influence of ANCAs associated with ulcerative colitis on the respiratory burst activity of neutrophils. PATIENTS: Serum samples were obtained from 14 patients with ulcerative colitis, seven of whom showed positivity for p-ANCAs, three patients with vasculitidis, two with positivity for p-ANCAs, and one for c-ANCAs, and seven healthy volunteers.
METHODS: A positive ANCA serology was determined with a standard indirect immunofluorescence assay. Purified immunoglobulins (IgGs) were prepared from serum samples by DEAE-Affigel blue chromatography. Human neutrophils were prepared by dextran-Ficoll-Hypaque separation. Superoxide anion (O2-.) generation was measured by following the superoxide dismutase inhibitable reduction of ferricytochrome.
RESULTS: There were no significant differences among samples from ulcerative colitis IgG p-ANCA positive, ulcerative colitis IgG p-ANCA negative patients, and controls on O2-. production, whereas ANCA positive IgG from vasculitidis significantly enhanced O2-. release (p < 0.001).
CONCLUSIONS: p-ANCAs associated with ulcerative colitis have no effect on the respiratory burst activity of normal human neutrophils in vitro. These results reinforce the hypotheses that ANCAs are unlikely to contribute to the pathogenesis of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155584      PMCID: PMC1027016          DOI: 10.1136/gut.40.1.102

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells.

Authors:  B H Ewert; J C Jennette; R J Falk
Journal:  Kidney Int       Date:  1992-02       Impact factor: 10.612

2.  Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.

Authors:  R H Duerr; S R Targan; C J Landers; N F LaRusso; K L Lindsay; R H Wiesner; F Shanahan
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

3.  Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity.

Authors:  F Shanahan; R H Duerr; J I Rotter; H Yang; L R Sutherland; C McElree; C J Landers; S R Targan
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

4.  Antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.

Authors:  J C Jennette; R J Falk
Journal:  Am J Clin Pathol       Date:  1993-03       Impact factor: 2.493

5.  Neutrophil autoantibodies in inflammatory bowel disease: are they important?

Authors:  F Shanahan
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

6.  A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.

Authors:  J A Rump; J Schölmerich; V Gross; M Roth; R Helfesrieder; A Rautmann; J Lüdemann; W L Gross; H H Peter
Journal:  Immunobiology       Date:  1990-11       Impact factor: 3.144

7.  Antibodies against granule proteins activate neutrophils in vitro.

Authors:  L A Charles; M L Caldas; R J Falk; R S Terrell; J C Jennette
Journal:  J Leukoc Biol       Date:  1991-12       Impact factor: 4.962

8.  Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells.

Authors:  C O Savage; B E Pottinger; G Gaskin; C D Pusey; J D Pearson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

Review 9.  Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.

Authors:  C G Kallenberg; A H Mulder; J W Tervaert
Journal:  Am J Med       Date:  1992-12       Impact factor: 4.965

Review 10.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

View more
  5 in total

Review 1.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis.

Authors:  J Mallolas; M Esteve; E Rius; E Cabré; M A Gassull
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

Review 3.  Antibody markers in the diagnosis of inflammatory bowel disease.

Authors:  Keiichi Mitsuyama; Mikio Niwa; Hidetoshi Takedatsu; Hiroshi Yamasaki; Kotaro Kuwaki; Shinichiro Yoshioka; Ryosuke Yamauchi; Shuhei Fukunaga; Takuji Torimura
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 4.  A Review of Selected IBD Biomarkers: From Animal Models to Bedside.

Authors:  Emiko Mizoguchi; Renuka Subramaniam; Toshiyuki Okada; Atsushi Mizoguchi
Journal:  Diagnostics (Basel)       Date:  2021-01-30

5.  A novel chemotaxis assay in 3-D collagen gels by time-lapse microscopy.

Authors:  Angela Vasaturo; Sergio Caserta; Ilaria Russo; Valentina Preziosi; Carolina Ciacci; Stefano Guido
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.